ABCG2 reduces ROS-mediated toxicity and inflammation: A potential role in Alzheimer's disease

Journal of Neurochemistry

Volumn 114, Issue 6, 2010, Pages 1590-1604

  Shen, Shanshan ^a,b   Callaghan, Debbie ^b   Juzwik, Camille ^b,c   Xiong, Huaqi ^b   Huang, Peilin ^a   Zhang, Wandong ^a,b,c  

^a SOUTHEAST UNIVERSITY   (China)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

ABCG2 up regulation; Alzheimer's disease; neuroinflammation; NF B; reactive oxygen species mediated toxicity and inflammation

Indexed keywords

AMYLOID BETA PROTEIN; BREAST CANCER RESISTANCE PROTEIN; HEME; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; REACTIVE OXYGEN METABOLITE; ABC TRANSPORTER; ABCG2 PROTEIN, HUMAN; ABCG2 PROTEIN, MOUSE; AMYLOID BETA PROTEIN[1-40]; AMYLOID PRECURSOR PROTEIN; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; CXCL2 PROTEIN, HUMAN; HEMIN; HYDROGEN PEROXIDE; PEPTIDE FRAGMENT; TERT BUTYL HYDROPEROXIDE; TUMOR PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN TISSUE; CELL PROTECTION; CONTROLLED STUDY; GENE EXPRESSION; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; KNOCKOUT MOUSE; MOUSE; NEUROPROTECTION; NONHUMAN; ONCOGENE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SIGNAL TRANSDUCTION; WILD TYPE; ANIMAL; BIOSYNTHESIS; BRAIN; CELL LINE; CELL SURVIVAL; GENETICS; METABOLISM; PHYSIOLOGY; TOXICITY; TUMOR CELL LINE;

MUS;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BRAIN; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; CHEMOKINE CXCL1; CHEMOKINE CXCL2; HEMIN; HUMANS; HYDROGEN PEROXIDE; INFLAMMATION; INTERLEUKIN-8; MICE; MICE, KNOCKOUT; NEOPLASM PROTEINS; NF-KAPPA B; PEPTIDE FRAGMENTS; REACTIVE OXYGEN SPECIES; TERT-BUTYLHYDROPEROXIDE;

EID: 77956313661     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06887.x     Document Type: Article

References (56)

1. Atamna H. (2006) Heme binding to amyloid-beta peptide: mechanistic role in Alzheimer's disease. J. Alzheimers Dis. 10, 255 266.
2. Atamna H. Boyle K. (2006) Amyloid-beta peptide binds with heme to form a peroxidase: relationship to the cytopathologies of Alzheimer's disease. Proc. Natl Acad. Sci. USA 103, 3381 3386.
3. Atamna H. Frey W. H. (2004) A role for heme in Alzheimer's disease: heme binds amyloid β and has altered metabolism. Proc. Natl Acad. Sci. USA 101, 11153 11158.
4. Atamna H., Liu J. Ames B. N. (2001) Heme deficiency selectively interrupts assembly of mitochondrial complex IV in human fibroblasts: revelance to aging. J. Biol. Chem. 276, 48410 48416.
5. Atamna H., Killilea D. W., Killilea A. N. Ames B. N. (2002) Heme deficiency may be a factor in the mitochondrial and neuronal decay of aging. Proc. Natl Acad. Sci. USA 99, 14807 14812.
6. Atwood C. S., Scarpa R. C., Huang X., Moir R. D., Jones W. D., Fairlie D. P., Tanzi R. E. Bush A. I. (2000) Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42. J. Neurochem. 75, 1219 1233.
7. Baeuerle P. A. Baltimore D. (1988) I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science 242, 540 546.
8. Beg A. A. Baldwin Jr. A. S. (1993) The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors. Genes Dev. 7, 2064 2070.
9. Borghi R., Patriarca S., Traverso N., Piccini A., Storace D., Garuti A., Gabriella C., Patrizio O. Massimo T. (2007) The increased activity of BACE1 correlates with oxidative stress in Alzheimer's disease. Neurobiol. Aging 28, 1009 1014.
10. Brechbuhl H. M., Gould N., Kachadourian R., Riekhof W. R., Voelker D. R. Day B. J. (2010) Glutathione transport is a unique function of the ATP-binding cassette protein ABCG2. J. Biol. Chem. 285, 16582 16587.
11. Brockman J. A., Scherer D. C., McKinsey T. A., Hall S. M., Qi X., Lee W. Y. Ballard D. W. (1995) Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation. Mol. Cell. Biol. 15, 2809 2818.
12. Brown K., Gerstberger S., Carlson L., Franzoso G. Siebenlist U. (1995) Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science 267, 1485 1488.
13. Burden A. E., Wu C., Dailey T. A., Busch J. L., Dhawan I. K., Rose J. P., Wang B. Dailey H. A. (1999) Human ferrochelatase: crystallization, characterization of the [2Fe-2S] cluster and determination that the enzyme is a homodimer. Biochim. Biophys. Acta 1435, 191 197.
14. Cadenas E. Davies K. J. (2000) Mitochondrial free radical generation, oxidative stress, and aging. Free Radic. Biol. Med. 29, 222 230.
15. Calabrese V., Guagliano E., Sapienza M., Panebianco M., Calafato S., Puleo E., Pennisi G., Mancuso C., Butterfield D. A. Stella A. G. (2007) Redox regulation of cellular stress response in aging and neurodegenerative disorders: role of vitagenes. Neruochem. Res. 32, 757 773.
16. Chen X. L. Kunsch C. (2004) Induction of cytoprotective genes through Nrf2/antioxidant response element pathway: a new therapeutic approach for the treatment of inflammatory diseases. Curr. Pharm. Des. 10, 879 891.
17. Chong I. W., Shi M. M., Love J. A., Christiani D. C. Paulauskis J. D. (2000) Regulation of chemokine mRNA expression in a rat model of vanadium-induced pulmonary inflammation. Inflammation 24, 505 517.
18. Connor J. R., Milward E. A., Moalem S., Sampietro M., Boyer P., Percy M. E., Vergani C., Scott R. J. Chorney M. (2001) Is hemochromatosis a risk factor for Alzheimer's disease? J. Alzheimers Dis. 3, 471 477.
19. Cullen K. M., Kocsi Z. Stone J. (2006) Microvascular pathology in the aging human brain: evidence that senile plaques are sites of microhaemorrhages. Neurobiol. Aging 27, 1786 1796.
20. Doyle L. A. Ross D. D. (2003) Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene 22, 7340 7358.
21. Duyckaerts C., Brion J. P., Hauw J. J. Flament-Durand J. (1987) Quantitative assessment of the density of neurofibrillary tangles and senile plaques in senile dementia of the Alzheimer type. Comparison of immunocytochemistry with a specific antibody and Bodian's protargol method. Acta Neuropathol. 73, 167 170.
22. Fukuyama H., Ogawa M., Yamauchi H., Yamaguchi S., Kimura J., Yonekura Y. Konishi J. (1994) Altered cerebral energy metabolism in Alzheimer's disease: a PET study. J. Nucl. Med. 35, 1 6.
23. Ghosh A. K., Kumaragurubaran N. Tang J. (2005) Recent developments of structure based beta-secretase inhibitors for Alzheimer's disease. Curr. Top Med. Chem. 5, 1609 1622.
24. Gsell W., Jungkunz G. Riederer P. (2004) Functional neurochemistry of Alzheimer's disease. Curr. Pharm. Des. 10, 265 293.
25. Guglielmotto M., Aragno M., Autelli R. et al. (2009) The up-regulation of BACE1 mediated by hypoxia and ischemic injury: role of oxidative stress and HIF1alpha. J. Neurochem. 108, 1045 1056.
26. Hardy J. (1997) Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20, 154 159.
27. Honda K., Smith M. A., Zhu X. et al. (2005) Ribosomal RNA in Alzheimer disease is oxidized by bound redox-active iron. J. Biol. Chem. 280, 20978 20986.
28. Jaramillo M. Olivier M. (2002) Hydrogen peroxide induces murine macrophage chemokine gene transcription via extracellular signal-regulated kinase- and cyclic adenosine 5′-monophosphate (cAMP)-dependent pathways: involvement of NF-kappa B, activator protein 1, and cAMP response element binding protein. J. Immunol. 169, 7026 7038.
29. Jonker J. W., Buitelaar M., Wagenaar E. et al. (2002) The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria. Proc. Natl Acad. Sci. USA 99, 15649 15654.
30. Karin M. Ben-Neriah Y. (2000) Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 18, 621 663.
31. Karin M., Liu Z. Zandi E. (1997) AP-1 function and regulation. Curr. Opin. Cell Biol. 9, 240 246.
32. Killilea D. W., Wong S. L., Cahaya H. S., Atamna H. Ames B. N. (2004) Iron accumulation during cellular senescence. Ann. N Y Acad. Sci. 1019, 365 367.
33. Krishnamurthy P., Ross D. D., Nakanishi T., Bailey-Dell K., Zhou S., Mercer K. E., Sarkadi B., Sorrentino B. P. Schuetz J. D. (2004) The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme. J. Biol. Chem. 279, 24218 24225.
34. Krishnamurthy P., Xie T. Schuetz J. D. (2007) The role of transporters in cellular heme and porphyrin homeostasis. Pharmacol. Ther. 114, 345 358.
35. Liu S. T., Howlett G. Barrow C. J. (1999) Histidine-13 is a crucial residue in the zinc ion-induced aggregation of the A beta peptide of Alzheimer's disease. Biochemistry 38, 9373 9378.
36. Lovell M. A., Robertson J. D., Teesdale W. J., Campbell J. L. Markesbery W. R. (1998) Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 158, 47 52.
37. Murayama T., Ohara Y., Obuchi M., Khabar K. S., Higashi H., Mukaida N. Matsushima K. (1997) Human cytomegalovirus induces interleukin-8 production by a human monocytic cell line, THP-1, through acting concurrently on AP-1- and NF- kappaB-binding sites of the interleukin-8 gene. J. Virol. 71, 5692 5695.
38. Perry R. T., Gearhart D. A., Wiener H. W., Harrell L. E., Barton J. C., Kutlar A., Kutlar F., Ozcan O., Go R. C. Hill W. D. (2008) Hemoglobin binding to Aβ and HBG2 SNP association suggest a role in Alzheimer's disease. Neurobiol. Aging 29, 185 193.
39. Pratico D., Uryu K., Leight S., Trojanoswki J. Q. Lee V. M. (2001) Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J. Neurosci. 21, 4183 4187.
40. Retz W., Gsell W., Munch G., Rosler M. Riederer P. (1998) Free radicals in Alzheimer's disease. J. Neural. Transm. 54, 221 236.
41. Rottkamp C. A., Raina A. K., Zhu X., Gaier E., Bush A. I., Atwood C. S., Chevion M., Perry G. Smith M. A. (2001) Redox-active iron mediates amyloid-beta toxicity. Free Radic. Biol. Med. 30, 447 450.
42. Smith M. A., Harris P. L., Sayre L. M. Perry G. (1997) Iron accumulation in Alzheimer disease is a source of redoxgenerated free radicals. Proc. Natl Acad. Sci. USA 94, 9866 9868.
43. Tamagno E., Guglielmotto M., Aragno M. et al. (2008) Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein. J. Neurochem. 104, 683 695.
44. Thakur A., Wang X., Siedlak S. L., Perry G., Smith M. A. Zhu X. (2007) c-Jun phosphorylation in Alzheimer disease. J. Neurosci. Res. 85, 1668 1673.
45. Verhaeghe C., Remouchamps C., Hennuy B., Vanderplasschen A., Chariot A., Tabruyn S. P., Oury C. Bours V. (2007) Role of IKK and ERK pathways in intrinsic inflammation of cystic fibrosis airways. Biochem. Pharmacol. 73, 1982 1994.
46. Vukic V., Callaghan D., Walker D., Lue L. F., Liu Q. Y., Couraud P. O., Romero I. A., Weksler B., Stanimirovic D. B. Zhang W. (2009) Expression of inflammatory genes induced by beta-amyloid peptides in human brain endothelial cells and in Alzheimer's brain is mediated by the JNK-AP1 signaling pathway. Neurobiol. Dis. 34, 95 106.
47. Wagner K. R., Sharp F. R., Ardizzone T. D., Lu A. Clark J. F. (2003) Heme and iron metabolism: role in cerebral hemorrhage. J. Cereb. Blood Flow Metab. 23, 629 652.
48. Walpen S., Beck K. F., Schaefer L., Raslik I., Eberhardt W., Schaefer R. M. Pfeilschifter J. (2001) Nitric oxide induces MIP-2 transcription in rat renal mesangial cells and in a rat model of glomerulonephritis. FASEB J. 15, 571 573.
49. Wu C. W., Liao P. C., Yu L., Wang S. T., Chen S. T., Wu C. M. Kuo Y. M. (2004) Hemoglobin promotes Abeta oligomer formation and localizes in neurons and amyloid deposits. Neurobiol. Dis. 17, 367 377.
50. Xiong H., Callaghan D., Jones A. et al. (2008) Cholesterol retention in Alzheimer's brain is responsible for high beta- and gamma-secretase activities and Abeta production. Neurobiol. Dis. 29, 422 437.
51. Xiong H., Callaghan D., Jones A. et al. (2009) ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides. J. Neurosci. 29, 5463 5475.
52. Zhang W. Stanimirovic D. B. (2005) The transport systems of the blood-brain barrier. in The blood-brain barrier and its microenvironment: Basic physiology to neurological disease (De Vries E. Prat A., eds), pp. 103 142. Taylor and Francis Group, New York.
53. Zhang W., Mojsilovic-Petrovic J., Andrade M. F., Zhang H., Ball M. Stanimirovic D. B. (2003) Expression and functional characterization of ABCG2 in brain endothelial cells and vessels. FASEB J. 17, 2085 2087.
54. Zhang W., Petrovic J. M., Callaghan D., Jones A., Cui H., Howlett C. Stanimirovic D. B. (2006) Evidence that hypoxia-inducible factor-1 (HIF-1) mediates transcriptional activation of interleukin-1β (IL-1β) in astrocyte cultures. J. Neuroimmunol. 174, 63 73.
55. Zhou S., Schuetz J. D., Bunting K. D. et al. (2001) The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat. Med. 7, 1028 1034.
56. Zhu X., Raina A. K., Lee H. G., Casadesus G., Smith M. A. Perry G. (2004) Oxidative stress signalling in Alzheimer's disease. Brain Res. 1000, 32 39.